A detailed history of Royal Bank Of Canada transactions in Dario Health Corp. stock. As of the latest transaction made, Royal Bank Of Canada holds 62,600 shares of DRIO stock, worth $46,324. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62,600
Previous 9,102 587.76%
Holding current value
$46,324
Previous $10,000 600.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.78 - $1.45 $41,728 - $77,572
53,498 Added 587.76%
62,600 $70,000
Q2 2024

Aug 14, 2024

SELL
$1.09 - $1.9 $134,993 - $235,309
-123,847 Reduced 93.15%
9,102 $10,000
Q1 2024

Nov 05, 2024

BUY
$1.4 - $2.55 $173,385 - $315,809
123,847 Added 1360.66%
132,949 $203,000
Q1 2024

May 15, 2024

BUY
$1.4 - $2.55 $184,776 - $336,556
131,983 Added 13662.84%
132,949 $203,000
Q4 2023

Feb 14, 2024

SELL
$1.0 - $3.39 $2,703 - $9,163
-2,703 Reduced 73.67%
966 $1,000
Q3 2023

Nov 14, 2023

BUY
$2.6 - $4.23 $436 - $710
168 Added 4.8%
3,669 $12,000
Q2 2023

Aug 14, 2023

BUY
$3.2 - $4.33 $6,992 - $9,461
2,185 Added 166.03%
3,501 $14,000
Q1 2023

May 15, 2023

BUY
$3.79 - $6.22 $3,092 - $5,075
816 Added 163.2%
1,316 $5,000
Q4 2022

Feb 14, 2023

SELL
$3.53 - $5.49 $353 - $549
-100 Reduced 16.67%
500 $2,000
Q2 2022

Aug 15, 2022

SELL
$4.33 - $7.45 $3,589 - $6,176
-829 Reduced 58.01%
600 $4,000
Q1 2022

May 16, 2022

SELL
$5.84 - $13.61 $12,520 - $29,179
-2,144 Reduced 60.01%
1,429 $9,000
Q4 2021

Feb 14, 2022

SELL
$12.52 - $19.02 $368,864 - $560,367
-29,462 Reduced 89.18%
3,573 $45,000
Q3 2021

Nov 15, 2021

SELL
$10.47 - $20.87 $27,829 - $55,472
-2,658 Reduced 7.45%
33,035 $451,000
Q2 2021

Aug 16, 2021

BUY
$13.9 - $22.58 $496,132 - $805,947
35,693 New
35,693 $763,000

Others Institutions Holding DRIO

About DarioHealth Corp.


  • Ticker DRIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 23,295,000
  • Market Cap $17.2M
  • Description
  • DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...
More about DRIO
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.